These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23704123)

  • 41. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular epidemiology of hepatitis B virus in Dakar, Sénégal.
    Vray M; Debonne JM; Sire JM; Tran N; Chevalier B; Plantier JC; Fall F; Vernet G; Simon F; Mb PS
    J Med Virol; 2006 Mar; 78(3):329-34. PubMed ID: 16419106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
    Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
    Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
    Kwak MS; Cho EJ; Jang ES; Lee JH; Yu SJ; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():23-8. PubMed ID: 22156482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
    Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
    Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevalence of occult hepatitis B virus infection and its phylogenetic features among mother-teenager pairs].
    Dong XL; Yao QQ; Wang XC; Xu HT; Wang XL; Chen SY; Tang ZF; Zheng YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):210-3. PubMed ID: 23759222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes of serum HBsAg in HBeAg positive chronic hepatitis patients with sustained viral response to long-term lamivudine treatment].
    Chen JJ; Wang ZH; Ma SW; Chen YP; Peng J; Guo YB; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):416-20. PubMed ID: 18578990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genotype impact on long-term virological outcome of chronic hepatitis B virus infection.
    Malmström S; Eilard A; Larsson SB; Hannoun C; Norkrans G; Lindh M
    J Clin Virol; 2012 Aug; 54(4):321-6. PubMed ID: 22608364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.
    Zeng G; Wang Z; Wen S; Jiang J; Wang L; Cheng J; Tan D; Xiao F; Ma S; Li W; Luo K; Naoumov NV; Hou J
    J Viral Hepat; 2005 Nov; 12(6):609-17. PubMed ID: 16255762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C.
    Kobayashi M; Akuta N; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Saitoh S; Kobayashi M; Someya T; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2006 Jan; 78(1):60-7. PubMed ID: 16299721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
    Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG; Di Perri G
    Liver Int; 2013 Apr; 33(4):580-5. PubMed ID: 23311449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary results of HBV DNA testing of Polish haemophilia patients--lack of occult HBV infection.
    Windyga J; Brojer E; Gronowska A; Grabarczyk P; Mikulska K; Szczepanik AB; Stefańska E; Buczma A
    Haemophilia; 2006 Jul; 12(4):380-3. PubMed ID: 16834737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.